These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 19106213

  • 1. Abnormal autoregulation and tubuloglomerular feedback in prediabetic and diabetic OLETF rats.
    Hashimoto S, Yamada K, Kawata T, Mochizuki T, Schnermann J, Koike T.
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F598-604. PubMed ID: 19106213
    [Abstract] [Full Text] [Related]

  • 2. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T, Tomoda F, Kinuno H, Inoue H, Takata M.
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T, Kobayashi T, Kamata K.
    Eur J Pharmacol; 2006 May 24; 538(1-3):132-40. PubMed ID: 16678154
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
    Ogawa M, Hirawa N, Tsuchida T, Eguchi N, Kawabata Y, Numabe A, Negoro H, Hakamada-Taguchi R, Seiki K, Umemura S, Urade Y, Uehara Y.
    Nephrol Dial Transplant; 2006 Apr 24; 21(4):924-34. PubMed ID: 16384826
    [Abstract] [Full Text] [Related]

  • 5. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M, Takemura T, Yanagida H, Yoshioka K.
    Kidney Int; 2002 Jan 24; 61(1):113-24. PubMed ID: 11786091
    [Abstract] [Full Text] [Related]

  • 6. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK, Zhao ZS, Lee YJ, Lee KE, Kang SM, Choi D, Lim SK, Chung N, Lee HC, Cha BS.
    Diabetes Metab Res Rev; 2003 Jan 24; 19(6):487-93. PubMed ID: 14648808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Tomiyoshi Y, Sakemi T, Aoki S, Miyazono M.
    Nephron; 2002 Dec 24; 92(4):860-7. PubMed ID: 12399633
    [Abstract] [Full Text] [Related]

  • 9. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH.
    Diabetes Res Clin Pract; 2009 Feb 24; 83(2):176-82. PubMed ID: 19111363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N, Yokozawa T.
    J Pharm Pharmacol; 2006 Apr 24; 58(4):535-45. PubMed ID: 16597372
    [Abstract] [Full Text] [Related]

  • 12. Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics.
    Hashimoto S, Maoka T, Kawata T, Mochizuki T, Koike T, Shigematsu T.
    PLoS One; 2020 Apr 24; 15(12):e0242332. PubMed ID: 33270683
    [Abstract] [Full Text] [Related]

  • 13. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
    Matsuura T, Yamagishi S, Kodama Y, Shibata R, Ueda S, Narama I.
    Int J Tissue React; 2005 Apr 24; 27(2):59-62. PubMed ID: 16035649
    [Abstract] [Full Text] [Related]

  • 14. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S, Ohno Y, Aoki N.
    Metabolism; 2007 Oct 24; 56(10):1326-33. PubMed ID: 17884440
    [Abstract] [Full Text] [Related]

  • 15. Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus.
    Sakano K, Takahashi M, Mutoh M, Niho N, Komiya M, Sato H, Tanaka T, Sugimura T, Wakabayashi K.
    Carcinogenesis; 2007 Oct 24; 28(10):2193-8. PubMed ID: 17510084
    [Abstract] [Full Text] [Related]

  • 16. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Yamagishi S, Koga K, Inagaki Y, Amano S, Okamoto T, Takeuchi M.
    Drugs Exp Clin Res; 2002 Oct 24; 28(6):221-7. PubMed ID: 12776575
    [Abstract] [Full Text] [Related]

  • 17. Reversal of elevated cardiac expression of TGFbeta1 and endothelin-1 in OLETF diabetic rats by long-acting calcium antagonist.
    Jesmin S, Zaedi S, Maeda S, Mowa CN, Sakuma I, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 24; 231(6):907-12. PubMed ID: 16741022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S, Tachikawa T, Tobita K, Aoyama I, Takayama F, Enomoto A, Niwa T.
    Am J Kidney Dis; 2003 Mar 24; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [Abstract] [Full Text] [Related]

  • 20. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K, Mizuno A, Sano T, Noma Y, Shima K.
    Horm Metab Res; 1995 Sep 24; 27(9):398-402. PubMed ID: 8557237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.